UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Nature Medicine, 2022-01, Vol.28 (1), p.71-80

2022

Volltextzugriff (PDF)

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Nature Medicine, 2022-10, Vol.28 (10), p.2217-2217

2022

Volltextzugriff (PDF)

Progress and prospects: gene therapy for inherited immunodeficiencies

Gene therapy, 2009-11, Vol.16 (11), p.1285-1291

2009

Volltextzugriff (PDF)

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

Leukemia, 2011-09, Vol.25 (9), p.1471-1483

2011

Volltextzugriff (PDF)

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection

Gene therapy, 2012-03, Vol.19 (3), p.246-254

2012

Volltextzugriff (PDF)

Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors

Gene therapy, 2009-04, Vol.16 (4), p.509-520

2009

Volltextzugriff (PDF)

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1

Gene therapy, 2002-03, Vol.9 (5), p.320-326

2002

Volltextzugriff (PDF)

Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy

Gene therapy, 2005-04, Vol.12 (8), p.694-701

2005

Volltextzugriff (PDF)

Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency

Gene therapy, 2012-08, Vol.19 (8), p.872-876

2012

Volltextzugriff (PDF)

Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression

Gene therapy, 2008-08, Vol.15 (16), p.1167-1175

2008

Volltextzugriff (PDF)

Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34 + cells : implications for leukemogenesis in gene therapy

Leukemia, 2007-04, Vol.21 (4), p.754-763

2007

Volltextzugriff (PDF)

Genetic Variants Associated With Neutrophil Function in Aggressive Periodontitis and Healthy Controls

Journal of periodontology (1970), 2010-04, Vol.81 (4), p.527-534

2010

Volltextzugriff (PDF)

In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium

Gene therapy, 2001-11, Vol.8 (21), p.1665-1668

2001

Volltextzugriff (PDF)

Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences

Gene therapy, 2005-04, Vol.12 (8), p.715-723

2005

Volltextzugriff (PDF)

Chemotaxis of macrophages is abolished in the Wiskott‐Aldrich syndrome

British journal of haematology, 1998-06, Vol.101 (4), p.659-665

1998

Volltextzugriff (PDF)

Correction of SCID-X1 using an enhancerless Vav promoter

Human gene therapy, 2011-03, Vol.22 (3), p.263-270

2011

Volltextzugriff (PDF)

Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency

British journal of haematology, 2007-07, Vol.138 (1), p.94-96

2007

Volltextzugriff (PDF)

Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX

Gene therapy, 2006-01, Vol.13 (2), p.117-126

2006

Volltextzugriff (PDF)

Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis

Blood, 2000-05, Vol.95 (9), p.2943-2946

2000

Volltextzugriff (PDF)

Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12

British journal of cancer, 2007-07, Vol.97 (2), p.210-217

2007

Volltextzugriff (PDF)

Current progress on gene therapy for primary immunodeficiencies

Gene therapy, 2013-10, Vol.20 (10), p.963-969

2013

Volltextzugriff (PDF)

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor γ chain

British journal of haematology, 1998-11, Vol.103 (2), p.335-342

1998

Volltextzugriff (PDF)

Cutting Edge: The Wiskott-Aldrich Syndrome Protein Is Required for Efficient Phagocytosis of Apoptotic Cells

The Journal of immunology (1950), 2001-04, Vol.166 (8), p.4831-4834

2001

Volltextzugriff (PDF)

Dendritic Cells: The Bare Bones of Immunity

Current biology, 2004-11, Vol.14 (22), p.R965-R967

2004

Volltextzugriff (PDF)

Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector

Gene therapy, 2007-12, Vol.14 (23), p.1623-1631

2007

Volltextzugriff (PDF)

1 – 25 von 1.337

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.096)
Mit Volltextzugriff
(995)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(761)
Life Sciences & Biomedicine
(633)
Humans
(508)
Animals
(295)
Male
(268)
Biological And Medical Sciences
(213)
Female
(200)
Mice
(163)
Medical Sciences
(162)
Gene Therapy
(145)
Adult
(125)
Medicine, Research & Experimental
(115)
Research & Experimental Medicine
(115)
Middle Aged
(106)
Physical Sciences
(101)
Biotechnology & Applied Microbiology
(99)
Hematology
(90)
Immunology
(89)
Genetics & Heredity
(85)
Chemistry
(81)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Author Correction: Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott–Aldrich syndrome

Progress and prospects: gene therapy for inherited immunodeficiencies

Correction of murine Rag1 deficiency by self-inactivating lentiviral vector-mediated gene transfer

Scale-up and manufacturing of clinical-grade self-inactivating γ-retroviral vectors by transient transfection

Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors

Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1

Long-term preservation of retinal function in the RCS rat model of retinitis pigmentosa following lentivirus-mediated gene therapy

Critical Variables affecting clinical-grade production of the self-inactivating gamma-retroviral vector for the treatment of X-linked severe combined immunodeficiency

Lentiviral transduction of the murine lung provides efficient pseudotype and developmental stage-dependent cell-specific transgene expression

Ectopic retroviral expression of LMO2, but not IL2Rγ, blocks human T-cell development from CD34 + cells : implications for leukemogenesis in gene therapy

Genetic Variants Associated With Neutrophil Function in Aggressive Periodontitis and Healthy Controls

In vivo gene transfer to the mouse eye using an HIV-based lentiviral vector; efficient long-term transduction of corneal endothelium and retinal pigment epithelium

Lentiviral vectors transcriptionally targeted to hematopoietic cells by WASP gene proximal promoter sequences

Chemotaxis of macrophages is abolished in the Wiskott‐Aldrich syndrome

Correction of SCID-X1 using an enhancerless Vav promoter

Rituximab for the treatment of autoimmune cytopenias in children with immune deficiency

Permanent partial phenotypic correction and tolerance in a mouse model of hemophilia B by stem cell gene delivery of human factor IX

Wiskott-Aldrich syndrome protein is necessary for efficient IgG-mediated phagocytosis

Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12

Current progress on gene therapy for primary immunodeficiencies

Enhanced human cell engraftment in mice deficient in RAG2 and the common cytokine receptor γ chain

Cutting Edge: The Wiskott-Aldrich Syndrome Protein Is Required for Efficient Phagocytosis of Apoptotic Cells

Dendritic Cells: The Bare Bones of Immunity

Cell-specific and efficient expression in mouse and human B cells by a novel hybrid immunoglobulin promoter in a lentiviral vector

Aktive Filter

Suchergebnisse filtern